Lacidipine inhibits the activation of the transcription factor nf‐kappa b and the expression of adhesion molecules induced by pro‐oxidant signals on endothelial cells

Journal of Hypertension

Volumn 15, Issue 12, 1997, Pages 1633-1640

  Cominacini, Luciano ^a   Garbin, Ulisse ^a   Pasini, Anna Fratta ^a   Paulon, Tiziana ^a   Davoli, Anna ^a   Campagnola, Mario ^a   Marchi, Elisabetta ^a   Pastorino, Antonio M ^a   Gaviraghi, Giovanni ^a   Cascio, Vincenzo Lo ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Adhesion molecules; Human umbilical vein endothelial cells; Lacidipine; Oxidized low density lipoprotein; Transcription factor NF kappa B; Tumor necrosis factor a

Indexed keywords

ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; CELL ADHESION MOLECULE; COPPER ION; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LACIDIPINE; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROSIS; CELL ADHESION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENDOTHELIUM; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0031458467     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199715120-00065     Document Type: Article

References (54)

1. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA: Interleukin-1 acts on cultured vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 1985, 76:2003-2011.
2. Libby P, Hanson GK: Biology of disease. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991, 64:5-13.
3. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, et al.: Expression of MCP-1 in macrophage-rich areas of human and rabbit atherosclerotic lesion. Proc Natl Acad Sci USA 1991, 88:5252-5256.
4. Haijar DP, Pomerantz KB: Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network. FASEB J 1992, 6:2933-2941.
5. Clinton SK, Underwood R, Hayes L, Sherman LM, Kufe DW, Libby P: Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesion of rabbits and humans. Am J Pathol 1992, 140:301-316.
6. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ: Genetic control of inflammatory gene induction and NF-κB-like transcription factor activation in response to an atherogenetic diet in mice. J Clin Invest 1993, 91:2572-2579.
7. Carlos TM, Schwartz BR, Kovach NL, Yee E, Rosa M, Osborn L, et al.; Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 1990, 76:965-970.
8. Rollins BJ, Yoshimura T, Leonard EJ, Pober JS: Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant MCP-1/JE. Am J Pathol 1990, 136:1229-1233.
9. Osborn L: Leukocyte adhesion to endothelium in inflammation. Cell 1990, 62:3-6.
10. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA: Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 1993, 92:471-478.
11. Hahne M, Jager U, Isenmann S, Hallmann R, Vestweber D: Five tumor necrosis factor-inducible cell adhesion mechanisms on the surface of mouse endothelioma cells mediate the binding of leukocytes. J Cell Biol 1993, 121:655-664.
12. Pober JS, Gimbrone MA, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, et al.: Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor and immune interferon. J Immunol 1986, 137:1893-1896.
13. Whelan J, Ghersa P, van Huijsduijnen RH, Gray J, Chandra G, Talabot F, et al.: An NF-κB-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule (ELAM-1) gene transcription. Nucleic Acids Res 1991, 19:2645-2653.
14. Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T: Functional analysis of the human vascular cell adhesion molecule-1 promoter. J Exp Med 1992, 176:1583-1593.
15. Ritchie AJ, Johnson DR, Ewenstein BM, Pober JS: Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation. J Immunol 1991, 146:3056-3062.
16. Friedl HP, Till GO, Ryan US, Ward P: Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J 1989, 3:2512-2518.
17. Avogaro P, Bittolo Bon G, Cazzolata G: Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988, 8:79-87.
18. Boyd H, Gown AM, Wolfbauer G, Chait A: Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol 1989, 135:815-824.
19. Steinberg D, Parthasarathy MD, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med 1989, 320:915-924.
20. Rosenfeld ME: Oxidized LDL affects multiple atherogenic cellular responses. Circulation 1991, 83:2137-2140.
21. Wiklund O, Mattson L, Bjornheden T, Camejo G, Bondjers G: Uptake and degradation of low density lipoproteins in atherosclerotic rabbit aorta: role of local LDL modification. J Lipid Res 1991, 32:55-62.
22. Cominacini L, Garbin U, Fratta Pasini A, Davoli A, Campagnola M, Contessi GB, et al.: Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Rad Biol Med 1997, 22:117-127.
23. Winrow VR, Winyard PG, Morris CJ, Blake DR: Free radicals in inflammation: second messengers and mediators of tissue destruction. Br Med Bull 1993, 49:506-522.
24. Matsubara T, Ziff M: Increased superoxide anion release in response to cytokines. J Immunol 1986, 137:3295-3298.
25. Voraberger G, Schafer R, Strotowa C: Cloning of the human gene for intercellular adhesion molecule-1 and analysis of its 5'-regulatory region. J Immunol 1991, 14:2777-2786.
26. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC: Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 1992, 267:16323-16329.
27. Lenardo MJ, Baltimore D: NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989, 58:227-229.
28. Ghosh S, Baltimore D: Activation in vitro of NF-κB by phosphorylation of its inhibitor IkB. Nature 1990, 344:678-682.
29. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991, 10:2247-2258.
30. van Amsterdam FTM, Roveri A, Maiorino M, Ratti E, Ursini F: Lacidipine: a dihydropyridine calcium antagonist with antioxidant activity. Free Rad Biol Med 1992, 12:183-187.
31. Havel RJ, Eder MA, Bragdon JM: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955, 34:1345-1353.
32. Cominacini L, Garbin U, Davoli A, Micciolo R, Bosello O, Gaviraghi G, et al.: A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J Lipid Res 1991, 32:349-358.
33. Cominacini L, Garbin U, De Santis A, Campagnola M, Davoli A, Fratta Pasini A, et al.: Mechanisms involved in the in vitro modification of low density lipoprotein by human umbilical vein endothelial cells and copper ions. J Lipid Med 1996, 13:19-33.
34. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al.: Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 105:293-299.
35. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973, 52:2745-2752.
36. Smith CW: Cooperative interactions of LFA-1 and Mac 1 with ICAM-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 1989, 83:2008-2013.
37. Landegren U: Measurement of cell numbers by means of the endogenous enzyme hexosaminidase: application to detection of lymphokines and cell surface antigens. J Immunol Methods 1984, 67:379-385.
38. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983, 11:1475-1489.
39. Godfraind T: Classification of calcium antagonists. Am J Cardiol 1987, 59:11B-23B.
40. Vanhoutte PM: The expert committee of the World Health Organization on classification of calcium antagonists: the viewpoint of the rapporteur. Am J Cardiol 1987, 59:3A-8A.
41. Jeng JR, Chang CH, Shieh SM, Chiu HC: Oxidized low-density lipoprotein enhances monocyte-endothelial cell binding against shear-stress-induced detachment. Biochim Biophys Acta 1993, 1178:221-227.
42. Khan BV, Parthasarathy SS, Alexander RW, Medford RM: Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 1995, 95:1262-1270.
43. Himmel HM, Whorton AR, Strauss HC: Intracellular calcium, currents and stimulus: response coupling in endothelial cell. Hypertension 1993, 21:112-127.
44. Sen CK, Packer L: Antioxidant and redox regulation of gene transcription. FASEB J 1996, 10:709-720.
45. Collins T: Endothelial nuclear factor-kB and the initiation of the atherosclerotic lesion. Lab Invest 1993, 68:499-508.
46. Weber C, Erl W, Pietsch A, Strobel M, Loms Ziegler-Heitbrock HW, Weber PC: Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulate to generate radicals. Arterioscler Thromb 1994, 14:1665-1673.
47. Tsao PS, Buitrago R, Chan JR, Cooke JP: Fluid flow inhibits endothelial adhesiveness: nitric oxide and transcriptional regulation of VCAM-1. Circulation 1996, 94:1682-1689.
48. Schreck R, Meier B, Mannel DM, Droge W, Baeuerle PA: Dithiocarbamates as potent inhibitors of nuclear factor-kB activation in intact cells. J Exp Med 1992, 175:1181-1194.
49. Terada LS, Willingha IR, Rosandich ME, Leff JA, Kindt GW, Repine JE: Generation of superoxide anion by brain endothelial cell xanthine oxidase. J Cell Physiol 1991, 148:191-196.
50. Pritchard KA, Wong PYK, Stemerman MB: Atherogenic concentrations of low-density lipoprotein enhance endothelial cell generation of epoxyeicosatetrainoic acid products. Am J Pathol 1990, 136:1383-1391.
51. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, et al.: Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993, 92:1866-1874.
52. Bauskin A, Alkalay I, Ben-Neriah Y: Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum. Cell 1991, 66:685-696.
53. Henkel T, Mackleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle PA: Rapid proteolysis of IkB-alpha is necessary for activation of transcription factor NF-κB. Nature 1993, 365:182-185.
54. Haller H, Schaper D, Ziegler W, Philipp S, Kuhlmann M, Distler A, Luft FC: Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells. Hypertension 1995, 25:511-516.